{"url_path":"/sec/adxn/10-k/2026/item-2","section_key":"item-2","section_title":"Item 2 Offer Statistics and Expected Timetable.","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1574232/0001104659-26-062447-index.html","accession_number":"0001104659-26-062447","cik":"0001574232","ticker":"ADXN","issuer_name":"Addex Therapeutics Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1574232/0001104659-26-062447-index.html","primary_entity_key":"0001574232","primary_entity_name":"Addex Therapeutics Ltd."},"word_count":9,"has_tables":true,"body_markdown":"Item 2. Offer Statistics and Expected Timetable.\n\nNot applicable."}